Sleep loss activates cellular inflammation and signal transducer and activator of transcription (STAT) family proteins in humans

Brain, Behavior, and Immunity

Volumn 47, Issue , 2015, Pages 86-92

  Irwin, Michael R ^a   Witarama, Tuff ^a   Caudill, Marissa ^a   Olmstead, Richard ^a   Breen, Elizabeth Crabb ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Flow cytometry; Humans; Immunology; Inflammation; Interleukin 6; Monocytes; Signal transducer and activator of transcription; Sleep; Sleep deprivation; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 6; STAT PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; STAT1 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN EXPERIMENT; IMMUNOREGULATION; INFLAMMATION; LYMPHOCYTE; MALE; MICROENVIRONMENT; MOLECULAR DYNAMICS; MONOCYTE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REM SLEEP; SIGNAL TRANSDUCTION; SLEEP DEPRIVATION; SLEEP TIME; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL;

ADULT; AGED; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MONOCYTES; SLEEP DEPRIVATION; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84930759268     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.09.017     Document Type: Article

References (59)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association, Washington, DC.
2. Baune B.T., Rothermundt M., Ladwig K.H., Meisinger C., Berger K. Systemic inflammation (Interleukin 6) predicts all-cause mortality in men: results from a 9-year follow-up of the MEMO Study. Age (Dordr.) 2011, 33:209-217.
3. Besedovsky L., Lange T., Born J. Sleep and immune function. Pflugers Arch. 2012, 463:121-137.
4. Bierhaus A., Wolf J., Andrassy M., Rohleder N., Humpert P.M., Petrov D., Ferstl R., von Eynatten M., Wendt T., Rudofsky G., Joswig M., Morcos M., Schwaninger M., McEwen B., Kirschbaum C., Nawroth P.P. A mechanism converting psychosocial stress into mononuclear cell activation. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:1920-1925.
5. Bornivelli C., Alivanis P., Giannikouris I., Arvanitis A., Choustoulakis I., Georgopoulou K., Karvouniaris N., Zervos A. Relation between insomnia mood disorders and clinical and biochemical parameters in patients undergoing chronic hemodialysis. J. Nephrol. 2008, 21(Suppl 13):S78-83.
6. Burgos I., Richter L., Klein T., Fiebich B., Feige B., Lieb K., Voderholzer U., Riemann D. Increased nocturnal interleukin-6 excretion in patients with primary insomnia: a pilot study. Brain Behav. Immun. 2006, 20:246-253.
7. Chiu Y.L., Chuang Y.F., Fang K.C., Liu S.K., Chen H.Y., Yang J.Y., Pai M.F., Peng Y.S., Wu K.D., Tsai T.J. Higher systemic inflammation is associated with poorer sleep quality in stable haemodialysis patients. Nephrol. Dial. Transpl. 2009, 24:247-251.
8. Dew M.A., Hoch C.C., Buysse D.J., Monk T.H., Begely A.E., Houck P.R., Hall M., Kupper D.J., Reynold C.F. Healthy older adults' sleep predicts all-cause mortality at 4 to 19years of follow-up. Psychosom. Med. 2003, 65:63-73.
9. DiDonato J.A., Mercurio F., Karin M. NF-kappaB and the link between inflammation and cancer. Immunol. Rev. 2012, 246:379-400.
10. Dimitrov S., Lange T., Benedict C., Nowell M.A., Jones S.A., Scheller J., Rose-John S., Born J. Sleep enhances IL-6 trans-signaling in humans. FASEB J. 2006, 20:2174-2176.
11. Ferrie J.E., Kivimaki M., Akbaraly T.N., Singh-Manoux A., Miller M.A., Gimeno D., Kumari M., Davey Smith G., Shipley M.J. Associations between change in sleep duration and inflammation: findings on C-reactive protein and interleukin 6 in the Whitehall II Study. Am. J. Epidemiol. 2013, 178:956-961.
12. Ferrie J.E., Shipley M.J., Cappuccio F.P., Brunner E., Miller M.A., Kumari M., Marmot M.G. A prospective study of change in sleep duration: associations with mortality in the Whitehall II cohort. Sleep 2007, 30:1659-1666.
13. Festa A., D'Agostino R., Howard G., Mykkanen L., Tracy R.P., Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000, 102:42-47.
14. Frey D.J., Fleshner M., Wright K.P. The effects of 40hours of total sleep deprivation on inflammatory markers in healthy young adults. Brain Behav. Immun. 2007, 21:1050-1057.
15. Gao B., Wang H., Lafdil F., Feng D. STAT proteins - key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver. J. Hepatol. 2012, 57:430-441.
16. Haack M., Kraus T., Schuld A., Dalal M., Koethe D., Pollmacher T. Diurnal variations of interleukin-6 plasma levels are confounded by blood drawing procedures. Psychoneuroendocrinology 2002, 27:921-931.
17. Haack M., Sanchez E., Mullington J.M. Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. Sleep 2007, 30:1145-1152.
18. Irwin M., Gillin J.C., Dang J., Weissman J., Phillips E., Ehlers C.L. Sleep deprivation as a probe of homeostatic sleep regulation in primary alcoholics. Biol. Psychiatry 2002, 51:632-641.
19. Irwin M., McClintick J., Costlow C., Fortner M., White J., Gillin J.C. Partial night sleep deprivation reduces natural killer and cellular immune responses in humans. FASEB J. 1996, 10:643-653.
20. Irwin, M., Olmstead, R., Breen, E., Witarama, T., Carrillo, C., Arevalo, J., Sadeghi, N., Ma, J., Nicassio, P., Ganz, P., Bower, J., Cole, S., in press. Tai Chi, cellular inflammation, and transcriptome dynamics in breast cancer survivors with insomnia: a randomized controlled trial. J. Natl. Cancer Inst.
21. Irwin M.R. Depression and insomnia in cancer: prevalence, risk factors, and effects on cancer outcomes. Curr. Psychiatry Rep. 2013, 15:404.
22. Irwin M.R. Why sleep is important for health: a psychoneuroimmunology perspective. Annu. Rev. Psychol. 2015, 66:2.1-2.30.
23. Irwin M.R., Carrillo C., Olmstead R. Sleep loss activates cellular markers of inflammation: sex differences. Brain Behav. Immun. 2010, 24:54-57.
24. Irwin M.R., Cole S.W. Reciprocal regulation of the neural and innate immune systems. Nat. Rev. Immunol. 2011, 11:625-632.
25. Irwin M.R., Olmstead R., Carrillo C., Sadeghi N., Fitzgerald J.D., Ranganath V.K., Nicassio P.M. Sleep loss exacerbates fatigue, depression, and pain in rheumatoid arthritis. Sleep 2012, 35:537-543.
26. Irwin M.R., Olmstead R., Carrillo C., Sadeghi N., Breen E., Witarama T., Nicassio P. Cognitive behavioral therapy vs. tai chi for late life insomnia and inflammatory risk: a randomized controlled efficacy trial. Sleep 2014, 37:1543-1552.
27. Irwin M.R., Wang M., Campomayor C.O., Collado-Hidalgo A., Cole S. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch. Intern. Med. 2006, 166:1756-1762.
28. Irwin M.R., Wang M., Ribeiro D., Cho H.J., Olmstead R., Breen E.C., Martinez-Maza O., Cole S. Sleep loss activates cellular inflammatory signaling. Biol. Psychiatry 2008, 64:538-540.
29. Irwin M.R., Ziegler M. Sleep deprivation potentiates activation of cardiovascular and catecholamine responses in abstinent alcoholics. Hypertension 2005, 45:252-257.
30. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006, 441:431-436.
31. Landen C.N., Lin Y.G., Armaiz Pena G.N., Das P.D., Arevalo J.M., Kamat A.A., Han L.Y., Jennings N.B., Spannuth W.A., Thaker P.H., Lutgendorf S.K., Savary C.A., Sanguino A.M., Lopez-Berestein G., Cole S.W., Sood A.K. Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer. Cancer Res. 2007, 67:10389-10396.
32. Laugsand L.E., Vatten L.J., Bjorngaard J.H., Hveem K., Janszky I. Insomnia and high-sensitivity C-reactive protein: the HUNT study, Norway. Psychosom. Med. 2012, 74:543-553.
33. Levy D.E., Lee C.K. What does Stat3 do?. J. Clin. Invest. 2002, 109:1143-1148.
34. Li Y., Zhang X., Winkelman J.W., Redline S., Hu F.B., Stampfer M., Ma J., Gao X. Association between insomnia symptoms and mortality: a prospective study of U.S. men. Circulation 2014, 129:737-746.
35. Liukkonen T., Rasanen P., Ruokonen A., Laitinen J., Jokelainen J., Leinonen M., Meyer-Rochow V.B., Timonen M. C-reactive protein levels and sleep disturbances: observations based on the Northern Finland 1966 Birth Cohort study. Psychosom. Med. 2007, 69:756-761.
36. Meier-Ewert H.K., Ridker P.M., Rifai N., Regan M.M., Price N.J., Dinges D.F., Mullington J.M. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J. Am. Coll. Cardiol. 2004, 43:678-683.
37. Miklossy G., Hilliard T.S., Turkson J. Therapeutic modulators of STAT signalling for human diseases. Nat. Rev. Drug Discov. 2013, 12:611-629.
38. Okun M.L., Hall M., Coussons-Read M.E. Sleep disturbances increase interleukin-6 production during pregnancy: implications for pregnancy complications. Reprod. Sci. 2007, 14:560-567.
39. Okun M.L., Hanusa B.H., Hall M., Wisner K.L. Sleep complaints in late pregnancy and the recurrence of postpartum depression. Behav. Sleep Med. 2009, 7:106-117.
40. Opp M.R. Sleep and psychoneuroimmunology. Immunol. Allergy Clin. North Am. 2009, 29:295-307.
41. Pace T.W., Mletzko T.C., Alagbe O., Musselman D.L., Nemeroff C.B., Miller A.H., Heim C.M. Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am. J. Psychiatry 2006, 163:1630-1633.
42. Parry B.L., Hauger R., LeVeau B., Mostofi N., Cover H., Clopton P., Gillin J.C. Circadian rhythms of prolactin and thyroid-stimulating hormone during the menstrual cycle and early versus late sleep deprivation in premenstrual dysphoric disorder. Psychiatry Res. 1996, 62:147-160.
43. Petrovsky N., Harrison L.C. Diurnal rhythmicity of human cytokine production. J. Immunol. 1997, 158:5163-5168.
44. Razeghi E., Sahraian M.A., Heidari R., Bagherzadeh M. Association of inflammatory biomarkers with sleep disorders in hemodialysis patients. Acta Neurol. Belg. 2012, 112:45-49.
45. Redwine L., Dang J., Hall M., Irwin M. Disordered sleep, nocturnal cytokines, and immunity in alcoholics. Psychosom. Med. 2003, 65:75-85.
46. Redwine L., Hauger R.L., Gillin J.C., Irwin M. Effects of sleep and sleep deprivation on interleukin-6, growth hormone, cortisol, and melatonin levels in humans. J. Clin. Endocrinol. Metab. 2000, 85:3597-3603.
47. Reuben D.B., Cheh A.I., Harris T.B., Ferrucci L., Rowe J.W., Tracy R.P., Seeman T.E. Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J. Am. Geriatr. Soc. 2002, 50:638-644.
48. Ridker P.M., Buring J.E., Cook N.R., Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation 2003, 107:391-397.
49. Ridker P.M., Cook N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores. Circulation 2004, 109:1955-1959.
50. Ridker P.M., Rifai N., Stampfer M.J., Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000, 101:1767-1772.
51. Shuai K., Liu B. Regulation of JAK-STAT signalling in the immune system. Nat. Rev. Immunol. 2003, 3:900-911.
52. van Leeuwen W.M., Lehto M., Karisola P., Lindholm H., Luukkonen R., Sallinen M., Harma M., Porkka-Heiskanen T., Alenius H. Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP. PLoS One 2009, 4:e4589.
53. Vgontzas A.N., Fernandez-Mendoza J., Liao D., Bixler E.O. Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. Sleep Med. Rev. 2013, 17:241-254.
54. Vgontzas A.N., Liao D., Pejovic S., Calhoun S., Karataraki M., Basta M., Fernandez-Mendoza J., Bixler E.O. Insomnia with short sleep duration and mortality: the Penn State cohort. Sleep 2010, 33:1159-1164.
55. Vgontzas A.N., Zoumakis E., Bixler E.O., Lin H.M., Follett H., Kales A., Chrousos G.P. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J. Clin. Endocrinol. Metab. 2004, 89:2119-2126.
56. Vgontzas A.N., Zoumakis M., Papanicolaou D.A., Bixler E.O., Prolo P., Lin H.M., Vela-Bueno A., Kales A., Chrousos G.P. Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime. Metabolism 2002, 51:887-892.
57. Volpato S., Guralnik J.M., Ferrucci L., Balfour J., Chaves P., Fried L.P., Harris T.B. Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation 2001, 103:947-953.
58. Yu H., Pardoll D., Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer 2009, 9:798-809.
59. Zhang J., Lamers F., Hickie I.B., He J.P., Feig E., Merikangas K.R. Differentiating nonrestorative sleep from nocturnal insomnia symptoms: demographic, clinical, inflammatory, and functional correlates. Sleep 2013, 36:671-679.